Literature DB >> 16000629

Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking.

Megan M Moran1, Krista McFarland, Roberto I Melendez, Peter W Kalivas, Jeremy K Seamans.   

Abstract

Withdrawal from chronic cocaine reduces extracellular glutamate levels in the nucleus accumbens by decreasing cystine/glutamate exchange (xc-). Activating xc- with N-acetylcysteine restores extracellular glutamate and prevents cocaine-induced drug seeking. It was hypothesized that the activation of xc- prevents drug seeking by increasing glutamatergic tone on presynaptic group II metabotropic glutamate receptors (mGluR2/3) and thereby inhibiting excitatory transmission. In the first experiment, the capacity of glutamate derived from xc- to regulate excitatory transmission via mGluR2/3 was determined. Physiological levels of cystine (100-300 nm) were restored to acute tissue slices from the nucleus accumbens or prefrontal cortex. Cystine increased glutamate efflux and decreased miniature EPSC (mEPSC) and spontaneous EPSC (sEPSC) frequency as well as evoked EPSC amplitude. These effects of cystine were presynaptic, because there was no change in mEPSC or sEPSC amplitude, and an increase in the evoked EPSC paired-pulse facilitation ratio. The cystine-induced reduction in EPSCs was reversed by blocking either xc- or mGluR2/3. In the second experiment, blocking mGluR2/3 prevented the ability of N-acetylcystine to inhibit the reinstatement of drug seeking in rats trained to self-administer cocaine. These data demonstrate that nonsynaptic glutamate derived from xc- modulates synaptic glutamate release and thereby regulates cocaine-induced drug seeking.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000629      PMCID: PMC1413952          DOI: 10.1523/JNEUROSCI.1007-05.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  25 in total

Review 1.  Pharmacological agents acting at subtypes of metabotropic glutamate receptors.

Authors:  D D Schoepp; D E Jane; J A Monn
Journal:  Neuropharmacology       Date:  1999-10       Impact factor: 5.250

2.  The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations.

Authors:  R S Petralia; Y X Wang; A S Niedzielski; R J Wenthold
Journal:  Neuroscience       Date:  1996-04       Impact factor: 3.590

3.  Modulation of extracellular glutamate concentration in rat brain slices by cystine-glutamate exchange.

Authors:  O Warr; M Takahashi; D Attwell
Journal:  J Physiol       Date:  1999-02-01       Impact factor: 5.182

Review 4.  Pharmacology and functions of metabotropic glutamate receptors.

Authors:  P J Conn; J P Pin
Journal:  Annu Rev Pharmacol Toxicol       Date:  1997       Impact factor: 13.820

5.  Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization.

Authors:  R C Pierce; K Bell; P Duffy; P W Kalivas
Journal:  J Neurosci       Date:  1996-02-15       Impact factor: 6.167

6.  Metabotropic glutamate receptors in the rat nucleus accumbens.

Authors:  O Manzoni; J M Michel; J Bockaert
Journal:  Eur J Neurosci       Date:  1997-07       Impact factor: 3.386

7.  Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin.

Authors:  D Jabaudon; K Shimamoto; Y Yasuda-Kamatani; M Scanziani; B H Gähwiler; U Gerber
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

8.  Differentiation of substrate and non-substrate inhibitors of transport system xc(-): an obligate exchanger of L-glutamate and L-cystine.

Authors:  Sarjubhai A Patel; Brady A Warren; Joseph F Rhoderick; Richard J Bridges
Journal:  Neuropharmacology       Date:  2004-02       Impact factor: 5.250

Review 9.  The ups and downs of addiction: role of metabotropic glutamate receptors.

Authors:  Paul J Kenny; Athina Markou
Journal:  Trends Pharmacol Sci       Date:  2004-05       Impact factor: 14.819

10.  Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: comparison between cocaine and a potent conventional reinforcer.

Authors:  Marco A S Baptista; Rémi Martin-Fardon; Friedbert Weiss
Journal:  J Neurosci       Date:  2004-05-19       Impact factor: 6.167

View more
  190 in total

Review 1.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.

Authors:  Jan Lewerenz; Sandra J Hewett; Ying Huang; Maria Lambros; Peter W Gout; Peter W Kalivas; Ann Massie; Ilse Smolders; Axel Methner; Mathias Pergande; Sylvia B Smith; Vadivel Ganapathy; Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2012-08-03       Impact factor: 8.401

Review 2.  New medications for drug addiction hiding in glutamatergic neuroplasticity.

Authors:  P W Kalivas; N D Volkow
Journal:  Mol Psychiatry       Date:  2011-04-26       Impact factor: 15.992

Review 3.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

Review 4.  Intercellular glutamate signaling in the nervous system and beyond.

Authors:  David E Featherstone
Journal:  ACS Chem Neurosci       Date:  2009-10-09       Impact factor: 4.418

Review 5.  Glutamatergic model psychoses: prediction error, learning, and inference.

Authors:  Philip R Corlett; Garry D Honey; John H Krystal; Paul C Fletcher
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

6.  Accumbens Mechanisms for Cued Sucrose Seeking.

Authors:  Ana-Clara Bobadilla; Constanza Garcia-Keller; Jasper A Heinsbroek; Michael D Scofield; Victoria Chareunsouk; Cara Monforton; Peter W Kalivas
Journal:  Neuropsychopharmacology       Date:  2017-07-20       Impact factor: 7.853

7.  Acamprosate attenuates cocaine- and cue-induced reinstatement of cocaine-seeking behavior in rats.

Authors:  M Scott Bowers; Billy T Chen; Jonathan K Chou; Megan P H Osborne; Justin T Gass; Ronald E See; Antonello Bonci; Patricia H Janak; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2007-09-02       Impact factor: 4.530

8.  N-acetylcysteine reduces extinction responding and induces enduring reductions in cue- and heroin-induced drug-seeking.

Authors:  Wenhua Zhou; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2007-08-24       Impact factor: 13.382

9.  Continuous intracerebroventricular infusion of the competitive NMDA receptor antagonist, LY235959, facilitates escalation of cocaine self-administration and increases break point for cocaine in Sprague-Dawley rats.

Authors:  Richard M Allen; Kristina A Uban; Elizabeth M Atwood; David S Albeck; Dorothy J Yamamoto
Journal:  Pharmacol Biochem Behav       Date:  2007-07-21       Impact factor: 3.533

10.  Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial.

Authors:  Annie Umbricht; Anthony DeFulio; Erin L Winstanley; D Andrew Tompkins; Jessica Peirce; Miriam Z Mintzer; Eric C Strain; George E Bigelow
Journal:  Drug Alcohol Depend       Date:  2014-04-16       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.